Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients

This study has been withdrawn prior to enrollment.
(The company decided not to start the study.)
Sponsor:
Collaborator:
The Cleveland Clinic
Information provided by (Responsible Party):
Janssen Diagnostics, LLC
ClinicalTrials.gov Identifier:
NCT02111031
First received: April 8, 2014
Last updated: June 18, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)